Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/1999
10/26/1999US5972937 Treating central nervous system disorders such as anxiety, depression, epilepsy, obsessive compulsive disorders, migraine, alzheimers disease, sleep disorders, feeding disorders such as anorexia and bulimia, panic attacks
10/26/1999US5972888 Lowering the production or release of neuropeptide y which comprises administering to a mammal in need thereof an effective amount of an isolated naturally occurring obesity protein, or a pharmaceutically acceptable salt thereof
10/21/1999WO1999052876A1 Azacycloalkane derivatives, preparation and therapeutic application
10/21/1999WO1999052870A1 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
10/21/1999WO1999052869A1 Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes
10/21/1999WO1999052861A1 Novel benzyl guanidine derivatives for therapy and in-vivo and in-vitro diagnosis
10/21/1999WO1999052539A1 Neo-tryptophan
10/21/1999WO1999044624A3 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy
10/21/1999WO1999043643A3 Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
10/21/1999DE19816929A1 New amino acid derivatives useful as neuropeptide Y agonists and/or antagonists for treating cardiovascular disorders, coronary, cerebral or renal vasospasms, obesity, bulimia and asthma
10/21/1999DE19816780A1 New tryptamine derivatives useful as antibacterial agents for treating infections in humans and especially animals
10/21/1999DE19816624A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
10/21/1999DE19816479A1 Intermolecular preparation of enamines by catalytic reaction of alkynes with ammonia or primary or secondary amines
10/21/1999CA2327477A1 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
10/20/1999EP0950661A1 Substituted tricyclics useful in sPLA2 induced diseases
10/20/1999EP0950657A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors
10/20/1999EP0950656A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
10/20/1999EP0950047A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/20/1999EP0949920A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
10/20/1999EP0740655B1 Metalloproteinase inhibitors
10/20/1999EP0708651B1 Therapeutic agent
10/20/1999CN1232452A NMDA (N-methyl-D-aspartate) antagonists
10/20/1999CN1232450A 2- and 2,5-substd. phenylketoenols
10/20/1999CN1045777C Tetracyclic derivs. process of preparation and use
10/19/1999US5969155 Conversion of trinitrotoluene into high value compounds
10/19/1999US5969133 Bioreductive cytotoxic agents
10/19/1999US5969079 Heat resistant, high strength aerospace engineering thermoplastics
10/19/1999US5968985 Benzoylguanidine derivatives as medicaments
10/19/1999US5968969 Stable, long acting salts of carboxamides for the treatment of joint disease
10/19/1999US5968945 Immunotherapeutic agents
10/19/1999US5968942 Inhibitors of hiv protease
10/19/1999US5968924 Benzo-fused lactams promote release of growth hormone
10/19/1999US5968795 Biaryl acetylenes as inhibitors of matrix metalloproteases
10/19/1999US5968479 Indole, fluorescent, and cyanine dyes; infrared endoscopy
10/17/1999CA2269262A1 Substituted tricyclics
10/17/1999CA2269256A1 Substituted tricyclics
10/16/1999CA2269049A1 N-acyl and n-aroyl aralkyl amides
10/14/1999WO1999051729A1 Pentaerythritol lipid derivatives
10/14/1999WO1999051605A1 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR
10/14/1999WO1999051591A2 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
10/14/1999WO1999051590A1 Substituted indolinones as kinase inhibitors
10/14/1999WO1999051577A1 (s)-2-(biphenyl-4-sulphonylamino)-3-(1h-indolyl)-propionic acid derivatives as matrix metal protein inhibitors
10/14/1999WO1999051576A1 N-aryloxyethylamine derivatives for the treatment of depression
10/14/1999WO1999051575A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
10/14/1999WO1999051574A1 Indole derivatives
10/14/1999WO1999051572A1 Sulfonamide derivatives
10/14/1999WO1999051569A1 Calcilytic compounds
10/14/1999WO1999051564A1 Propanolamine derivatives
10/14/1999WO1999051225A1 Antidiabetic agents
10/14/1999WO1999051224A1 Indolyl-3-glyoxylic acid derivatives with antitumoral activity
10/14/1999WO1999037604A3 Dialkyl ureas as calcitonin mimetics
10/14/1999DE19817517A1 New benzylguanidine derivatives useful for diagnosis or therapy, especially of neuroblastoma
10/14/1999DE19814838A1 Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung Indolyl-3-glyoxylic acid derivatives having anti-tumor activity
10/14/1999CA2328607A1 Antidiabetic agents
10/14/1999CA2327513A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
10/14/1999CA2327397A1 Indole derivatives
10/14/1999CA2327359A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
10/14/1999CA2327303A1 N-aryloxyethylamine derivatives for the treatment of depression
10/14/1999CA2327290A1 Sulfonamide derivatives
10/14/1999CA2327279A1 Calcilytic compounds
10/14/1999CA2326522A1 Pyrrolo¬1,2-a|pyrazine spla2 inhibitor
10/14/1999CA2325849A1 Pentaerythritol lipid derivatives
10/13/1999EP0948483A1 Farnesyl transferase inhibitors
10/13/1999EP0948327A1 Antidiabetic agents
10/13/1999CN1231665A Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/13/1999CN1045602C Tetrahydropyrido-indole derivant and medicinal composition and pharmaceutical use thereof
10/12/1999US5965745 Asthma; antiarthritic,-shock agents; bronchitis; respiratory system diseases, e.g. chronic obstructive airways diseases; psoriasis; allergic rhinitis; atopic dermatitis
10/12/1999US5965600 Preventive and therapeutic method for treating arteriosclerosis and articular rheumatism; providing minimal liver toxicity
10/12/1999US5965582 Antihistamines
10/07/1999WO1999050438A2 Chromogenic indole derivatives
10/07/1999WO1999050268A2 Substituted indolealkanoic acids
10/07/1999WO1999050246A1 Protein-carbohydrate binding antagonists
10/07/1999WO1999050245A1 Indole derivatives with antiviral activity
10/07/1999WO1999050229A1 Fatty acid analogs and prodrugs
10/07/1999WO1999049856A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999DE19815020A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
10/07/1999DE19814546A1 (S)-2-(Biphenyl-4-sulfonylamino)-3-(1H-indol-3-yl)-propionsäurederivate (S) -2- (biphenyl-4-sulfonylamino) -3- (1H-indol-3-yl) -propionic acid
10/07/1999CA2326166A1 Indole derivatives with antiviral activity
10/07/1999CA2325986A1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/06/1999EP0947507A1 Novel tetrahydrobenzindolone derivatives
10/06/1999EP0947506A1 2-Aza-bicyclo[2.2.1]heptane derivatives and their use as rotamase inhibitors
10/06/1999EP0946542A1 Indane or dihydroindole derivatives
10/06/1999EP0946539A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
10/06/1999EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity
10/06/1999EP0946509A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
10/06/1999EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
10/06/1999EP0946499A1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/06/1999EP0946496A2 Process for resolving mixtures of carbocyclic stereoisomers
10/06/1999EP0946478A1 Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
10/06/1999EP0946173A1 Preparation of 3-fluoro oxindole derivatives
10/06/1999EP0946172A1 Method for inhibiting stress-activated protein kinases
10/06/1999EP0946170A1 Inhibition of protein glycation and prevention of vasculopathy
10/06/1999EP0946166A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
10/06/1999EP0946097A1 Composition and use
10/06/1999EP0839133B1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors
10/06/1999CN1230960A Intermediates for preparation of duocarmycin SA and derivatives thereof, and process for production of intermdiates
10/06/1999CN1230948A Pyranoindole and carbazole inhibitors of COX-2
10/05/1999US5962725 Chemical intermediate; blocks reproduction of virus
10/05/1999US5962722 Used in peptide synthesis
10/05/1999US5962695 Aromatic amidine derivatives and salts thereof
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 458